Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biased Signaling as Allosteric Probe Dependence: Everything Old Is New Again.

Biochemistry·2026
Same author

Therapeutic implications of target residence time.

Current opinion in structural biology·2026
Same author

Structure-based design of an opioid receptor modulator for enhanced morphine analgesia.

Science advances·2026
Same author

Differential Effects of Sodium on Agonist-Induced Conformational Transitions and Signaling at μ and κ Opioid Receptors.

Biochemistry·2025
Same author

Agonism and Biased Signaling.

Handbook of experimental pharmacology·2025
Same author

Differential effects of sodium on agonist-induced conformational transitions and signaling at μ and κ opioid receptors.

bioRxiv : the preprint server for biology·2025
Same journal

Endothelial Cell Phenotypic Plasticity in Atherosclerosis.

Handbook of experimental pharmacology·2026
Same journal

Endothelial Dysfunction and Neurovascular Alterations in Autism Spectrum Disorder.

Handbook of experimental pharmacology·2026
Same journal

Molecular Mechanisms of Endothelial Shear Stress Mechanotransduction in Health and Disease.

Handbook of experimental pharmacology·2026
Same journal

Microvasculature of the Pancreatic Islets of Langerhans in Health and Diabetes.

Handbook of experimental pharmacology·2026
Same journal

Mechanisms of Actions of Physiological, Pharmacological, and Toxicological Dietary Bioactive Inorganic Boron.

Handbook of experimental pharmacology·2026
Same journal

BNCT Plus Luminescence: New Paradigm for Boron-Containing Drug Design.

Handbook of experimental pharmacology·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

6.2K

Quantifying biased β-arrestin signaling.

Terry Kenakin1

  • 1Department of Pharmacology, University of North Carolina School of Medicine, 120 Mason Farm Road, Room 4042, Genetic Medicine Building, CB# 7365, Chapel Hill, NC, 27599-7365, USA, Kenakin@email.unc.edu.

Handbook of Experimental Pharmacology
|December 3, 2013
PubMed
Summary
This summary is machine-generated.

Biased agonists can selectively activate specific signaling pathways, like β-arrestin signaling, for therapeutic benefit. This study details methods to quantify these biased effects, aiding drug optimization.

More Related Videos

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

11.9K
BRET-based G Protein Biosensors for Measuring G Protein-Coupled Receptor Activity in Live Cells
09:21

BRET-based G Protein Biosensors for Measuring G Protein-Coupled Receptor Activity in Live Cells

Published on: November 7, 2025

922

Related Experiment Videos

Last Updated: May 5, 2026

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

6.2K
Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

11.9K
BRET-based G Protein Biosensors for Measuring G Protein-Coupled Receptor Activity in Live Cells
09:21

BRET-based G Protein Biosensors for Measuring G Protein-Coupled Receptor Activity in Live Cells

Published on: November 7, 2025

922

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Drug Discovery

Background:

  • Receptor agonists can stabilize unique receptor conformations.
  • These conformations lead to biased signaling, not uniform activation of all downstream pathways.
  • β-arrestin signaling is a key system exhibiting biased signaling.

Purpose of the Study:

  • To discuss biased signaling, focusing on β-arrestin pathways.
  • To highlight the therapeutic potential of emphasizing or de-emphasizing β-arrestin signaling.
  • To present methods for quantifying biased signaling effects.

Main Methods:

  • Focus on methods to quantify biased signaling effects.
  • Description of methods to derive ΔΔLog(τ/K A) values.
  • Description of methods to derive ΔΔLog(Relative Activity) values.

Main Results:

  • Quantification methods provide scales for optimization.
  • These scales can be used to optimize biased agonism and antagonism.
  • Demonstration of how to derive specific quantitative values.

Conclusions:

  • Biased signaling offers a route to optimize drug effects.
  • Quantification of biased signaling is crucial for therapeutic benefit.
  • Methods described enable the optimization of biased agonists and antagonists.